Rp. Steeds et al., Human vascular reactivity and polymorphisms of the angiotensin-converting enzyme and the angiotensin type 1 receptor genes, J VASC RES, 36(6), 1999, pp. 445-455
Citations number
52
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
The D allele of the insertion (I)/deletion (D) polymorphism in the angioten
sin-converting enzyme (ACE) gene and the C allele of the A1166-C polymorphi
sm in the angiotensin II type 1 receptor (AGT1R) gene have been associated
with altered vascular structure and with an increased risk of myocardial in
farction. The aim of this study was to determine whether differences in vas
cular function could be demonstrated to link the previously described chang
es in structure and the disease outcome. 70 subjects were recruited at rand
om from patients undergoing colonic resection, resistance arteries were exc
ised and were mounted in a small vessel wire myograph. Vasomotor responses
to potassium chloride, noradrenaline, prostaglandin F-2 alpha, angiotensin
I, angiotensin II, acetylcholine and substance P were performed in 30 subje
cts, Genotype was established in a blinded fashion after completion of myog
raphy. To exclude the possibility of masking of genetic influence by non-AC
E conversion of angiotensin I, vasomotor responses were then performed to p
roline(10)-angiotensin I in a further 30 subjects and to angiotensin I in t
he presence of chymostatin in a further 10 subjects. No significant effect
of the I/D polymorphism of the ACE gene was seen on vasomotor function. The
C allele of the AGT1R gene was associated with an increase in sensitivity
to prostaglandin F-2 alpha but not with alteration to the other vasoactive
agents studied. The I/D ACE and A1166-C AGT1 receptor polymorphism do not a
ppear to result in differences in vasomotor function in isolated human mese
nteric resistance arterioles in subjects without evidence of underlying hyp
ertensive or cardiovascular disease. Copyright (C) 1999 S. Karger AG. Basel
.